David A. Siegel Kamada LTD Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Kamada LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 16,632 shares of KMDA stock, worth $113,762. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,632Holding current value
$113,762% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KMDA
# of Institutions
39Shares Held
5.03MCall Options Held
14.3KPut Options Held
2K-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$11.3 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny808KShares$5.53 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA609KShares$4.16 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny448KShares$3.07 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3330KShares$2.26 Million0.19% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $306M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...